Previously submitted to: JMIR Research Protocols (no longer under consideration since May 04, 2026)
Date Submitted: Jul 27, 2025
Open Peer Review Period: Jul 29, 2025 - Sep 23, 2025
(closed for review but you can still tweet)
European Registry for Transperineal Laser Ablation of Prostate (TPLA) for Lower Urinary Tract Symptoms (LUTS) due to Benign Prostatic Obstruction (BPO): study protocol of a prospective multicenter trial.
Background:
Transperineal Laser Ablation of Prostate (TPLA) is an emerging minimally invasive technique for the treatment of Benign Prostatic Obstruction (BPO).
Objective:
To design a multicenter prospective registry to collect data on patients treated with TPLA for BPO at several European referral centers to overcome the current limited evidence.
Methods:
The study is designed as a nonprofit prospective multicentre observational cohort registry. The primary objective is to assess the mid- and long-term effectiveness of TPLA. Secondary objectives are to assess functional and safety outcomes and to identify possible predictors of efficacy or failure of the technique. All candidates for TPLA among the participant centres will be evaluated for enrollment. The estimated number of patients enrolled at the end of the study is 2500. Data collection will include preoperative characteristics, intraoperative and postoperative outcomes, patient-reported measures using validated tools as well as complications. Descriptive and advanced statistical analyses, such as uni- and multivariate analyses, will be performed as appropriate depending on the variable examined.
Results:
Enrolment is ongoing, with 56 patients enrolled at the time of the submission of this manuscript. An interim analysis on both efficacy and safety is planned once a total of 100 patients have been enrolled, expected by the end of 2026. An interim analysis on both efficacy and safety is planned once a total of 100 patients have been enrolled. Subsequent analyses will be conducted annually to monitor long-term outcomes.
Conclusions:
This multicenter prospective registry aims to provide real-world data on the effectiveness, safety, and predictors of success for TPLA in the management of BPO. By generating comprehensive data across multiple centers, the study seeks to address current knowledge gaps and support the integration of TPLA into clinical practice guidelines, paving the way for future high-level comparative research.
ClinicalTrial:
The study has been approved by the local Ethical Committee in July 2024 (CEAVC25691) and it has been registered on ClinicalTrials.gov (NCT06564415).
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.